Your session is about to expire
← Back to Search
Behavioural Intervention
Electrical Stimulation for Post-Stroke Fatigue
N/A
Recruiting
Led By Hui-Ting Goh
Research Sponsored by Texas Woman's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have some movement capability in the more affected arm (upper extremity Fugl-Meyer(FMUE) ≥ 28) to ensure they can perform the reaching task
Be at least 18 years old
Must not have
The presence of significant depression (score > 10 on the Patient Health Questionnaire-9)
Significant pain in the upper extremities that interferes with movements
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this outcome will be assessed at 2 time points during the study, at baseline and immediately after the intervention ( an average of 7 days from baseline).
Summary
This trial will look at how 5-daily sessions of electrical stimulation can reduce fatigue after stroke. Fatigue will be measured using clinical, behavioral and neurophysiological outcomes.
Who is the study for?
This trial is for adults who've had a stroke at least 3 months ago, can follow simple instructions, and experience significant fatigue (scoring ≥4 on the Fatigue Severity Scale). They should be able to move their affected arm somewhat. People with acute health issues, contraindications to the study's procedures, severe depression, pain that affects arm movement or medications influencing fatigue levels cannot participate.
What is being tested?
The study tests if anodal transcranial direct current stimulation (tDCS) over part of the brain affected by stroke can reduce post-stroke fatigue. Participants will get either real or sham tDCS daily for five days. The effects on behavior and brain function are assessed before, right after treatment and one month later.
What are the potential side effects?
Transcranial direct current stimulation may cause mild side effects like itching, tingling or discomfort at the electrode site during application. Serious side effects are rare but could include skin burns or mood changes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can move my arm enough to reach out for things.
Select...
I am 18 years old or older.
Select...
I can understand and follow three-step instructions.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have significant depression, scoring over 10 on a depression scale.
Select...
I experience severe pain in my arms that affects my movement.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ this outcome will be assessed at 2 time points during the study, at baseline and immediately after the intervention ( an average of 7 days from baseline).
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this outcome will be assessed at 2 time points during the study, at baseline and immediately after the intervention ( an average of 7 days from baseline).
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Fatigue Severity Scale score
Input-output curve slope
Secondary study objectives
Borg Rating of Perceived Exertion
Fatigue Scale for Motor and Cognitive Function
Functional connectivity of the fronto-striato-thalamic network
+3 moreOther study objectives
Functional connectivity of other established brain networks.
Reach error
Reach movement time
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Anodal tDCS groupExperimental Treatment1 Intervention
Participants will receive anodal tDCS applied to the ipsilesional primary motor cortex.
Group II: Sham tDCSPlacebo Group1 Intervention
Participants will receive sham tDCS applied to the ipsilesional primary motor cortex
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Anodal transcranial direct current stimulation
2016
Completed Phase 3
~180
Find a Location
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,843 Previous Clinical Trials
8,173,201 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,068 Previous Clinical Trials
2,747,675 Total Patients Enrolled
Texas Woman's UniversityLead Sponsor
88 Previous Clinical Trials
5,902 Total Patients Enrolled
Hui-Ting GohPrincipal InvestigatorPhysical Therapy
2 Previous Clinical Trials
16 Total Patients Enrolled